Schedule 13D ownership disclosure
LEONABIO INC
Common Stock · CUSIP: 04746L203
Event date: 2026-10-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sermonix Pharmaceuticals, Inc.Reported CIK 0001655566
Shares: 3,149,470.00 · Class: 25.1%
- Portman David J.Reported CIK 0002126186
Shares: 3,149,470.00 · Class: 25.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001655566-26-000004
- Form type
- SCHEDULE 13D/A
- Filer
- Sermonix Pharmaceuticals, Inc.
- CIK
- CIK 1655566
- Filed
- Oct 28, 2026
- Reporting period
- Oct 26, 2026
- Description
- Schedule 13D beneficial ownership